Screener
Alamar Biosciences ALMR Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213424
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest expense | (223) | (46) |
| Loss on remeasurement of convertible notes | (8,594) | — |
| Other (expense) income, net | (236) | 154 |
| Net loss before income tax | (20,861) | (7,659) |
| Provision for income taxes | 464 | — |
| Net loss | $(21,325) | $(7,659) |
| Net loss per share, basic and diluted | $(1.74) | $(0.68) |
| Weighted-average common shares outstanding, basic and diluted | 12,259,811 | 11,258,870 |
Item 1. Financial Statements
FAQ
- What is Alamar Biosciences's pre-tax income?
- Alamar Biosciences (ALMR) reported pre-tax income of -$20.86M in Q1 2026.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Alamar Biosciences's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude